Capricor Therapeutics (CAPR) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $25.5 million.
- Capricor Therapeutics' Non-Current Assets rose 25754.29% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.5 million, marking a year-over-year increase of 6164.2%. This contributed to the annual value of $7.1 million for FY2024, which is 993.84% down from last year.
- As of Q3 2025, Capricor Therapeutics' Non-Current Assets stood at $25.5 million, which was up 25754.29% from $9.4 million recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Non-Current Assets registered a high of $25.5 million during Q3 2025, and its lowest value of $928489.0 during Q1 2021.
- Over the past 5 years, Capricor Therapeutics' median Non-Current Assets value was $7.1 million (recorded in 2024), while the average stood at $7.1 million.
- As far as peak fluctuations go, Capricor Therapeutics' Non-Current Assets surged by 46949.84% in 2022, and later crashed by 993.84% in 2024.
- Quarter analysis of 5 years shows Capricor Therapeutics' Non-Current Assets stood at $4.9 million in 2021, then surged by 47.26% to $7.2 million in 2022, then grew by 9.33% to $7.9 million in 2023, then decreased by 9.94% to $7.1 million in 2024, then surged by 259.18% to $25.5 million in 2025.
- Its last three reported values are $25.5 million in Q3 2025, $9.4 million for Q2 2025, and $7.5 million during Q1 2025.